UB Paderborn / Katalog / Suche / in CDI

The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety

Neuropharmacology, 2009-12, Vol.57 (7), p.608-618

2009

Volltextzugriff (PDF)

Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice

Phytomedicine (Stuttgart), 2014-09, Vol.21 (11), p.1382-1389

2014

Volltextzugriff (PDF)

P.1.g.074 Acquired binge-eating behaviour produces alterations in dopaminergic neurochemistry in the brains of rats

European neuropsychopharmacology, 2014-10, Vol.24, p.S246-S247

2014

Volltextzugriff (PDF)

Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

Experimental neurology, 2006-02, Vol.197 (2), p.284-290

2006

Volltextzugriff (PDF)

[ 3H]Nisoxetine—A radioligand for noradrenaline reuptake sites: Correlation with inhibition of [ 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments

Neuropharmacology, 1996, Vol.35 (1), p.63-70

1996

Volltextzugriff (PDF)

[ 3H]Paroxetine binding in rat frontal cortex strongly correlates with [ 3H]5-HT uptake: Effect of administration of various antidepressant treatments

Neuropharmacology, 1993-08, Vol.32 (8), p.737-743

1993

Volltextzugriff (PDF)

Evidence that RU 24969‐induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5‐HT1B receptor

British journal of pharmacology, 1993-12, Vol.110 (4), p.1621-1629

1993

Volltextzugriff (PDF)

Advantaged receptor binding profile distinguishes BTS 79 018 from other antipsychotics

European neuropsychopharmacology, 1999-09, Vol.9, p.261-261

1999

Volltextzugriff (PDF)

Evidence that RU 24969‐induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5‐HT 1B receptor

British journal of pharmacology, 1993-12, Vol.110 (4), p.1621-1629

1993

Volltextzugriff (PDF)

The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex

Neuropharmacology, 1999-09, Vol.38 (9), p.1421-1430

1999

Volltextzugriff (PDF)

Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine

Neuropharmacology, 2000-01, Vol.39 (11), p.2028-2035

2000

Volltextzugriff (PDF)

The effects of the peptide-coupling agent, EEDQ, on 5-HT 2A receptor binding and function in rat frontal cortex

Neuropharmacology, 1999, Vol.38 (9), p.1421-1430

1999

Volltextzugriff (PDF)

Zotepine: Preclinical support for antidepressant activity

Biological psychiatry (1969), 1997-07, Vol.42 (1), p.175S-176S

1997

Volltextzugriff (PDF)

Dopamine D2 receptors : a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments

Pharmacology, biochemistry and behavior, 1995-08, Vol.51 (4), p.565-569

1995

Volltextzugriff (PDF)

Dopamine D 2 receptors: A potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments

Pharmacology, biochemistry and behavior, 1995-08, Vol.51 (4), p.565-569

1995

Volltextzugriff (PDF)

Binding of zotepine to serotonin (5-HT) receptor subtypes

Schizophrenia research, 1996-02, Vol.18 (2), p.141-142

1996

Volltextzugriff (PDF)

Neurotransmitters and their receptors in post-mortem brain from depressed suicide victims

Cheetham, S.C

1988

Volltextzugriff (PDF)

[ 3H]5-hydroxytryptamine binding sites in postmortem human brain

Neuropharmacology, 1989-10, Vol.28 (10), p.1055-1060

1989

Volltextzugriff (PDF)

The inhibition constants for blockade of [3H]5-hydroxytryptamine reuptake are variable and dependent on a tissue concentration

European journal of pharmacology, 1990-07, Vol.183 (5), p.1901-1902

1990

Volltextzugriff (PDF)

CHAPTER 6 - POST-MORTEM STUDIES OF NEUROTRANSMITTER BIOCHEMISTRY IN DEPRESSION AND SUICIDE

Biological Aspects of Affective Disorders, 1991, p.191-221

1991

Volltextzugriff (PDF)

Brain 5-HT Uptake Sites, Labelled with [3H]Paroxetine, in Depressed Suicides

Presynaptic Receptors and Neuronal Transporters, 1991, p.237-238

1991

Volltextzugriff (PDF)

Key features of palliative care service delivery to Indigenous peoples in Australia, New Zealand, Canada and the United States: a comprehensive review

BMC palliative care, 2018-05, Vol.17 (1), p.72-72, Article 72

2018

Volltextzugriff (PDF)

An Exploration of Underrepresentation of Aboriginal Cancer Patients Attending a Regional Radiotherapy Service in Western Australia

International journal of environmental research and public health, 2018-02, Vol.15 (2), p.337

2018

Volltextzugriff (PDF)

Hypercalcaemia in relapsed medulloblastoma 8 years post-diagnosis; evidence to support PTHrP production by medulloblastoma cells

Hormone research, 2006-01, Vol.66 (6), p.268-272

2006

Volltextzugriff (PDF)

Hydroxyapatite Ceramics from Hydrothermally Prepared Powders

MRS proceedings, 1994, Vol.346, Article 237

1994

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety

Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice

P.1.g.074 Acquired binge-eating behaviour produces alterations in dopaminergic neurochemistry in the brains of rats

Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

[ 3H]Nisoxetine—A radioligand for noradrenaline reuptake sites: Correlation with inhibition of [ 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments

[ 3H]Paroxetine binding in rat frontal cortex strongly correlates with [ 3H]5-HT uptake: Effect of administration of various antidepressant treatments

Evidence that RU 24969‐induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5‐HT1B receptor

Advantaged receptor binding profile distinguishes BTS 79 018 from other antipsychotics

Evidence that RU 24969‐induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5‐HT 1B receptor

The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex

Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine

The effects of the peptide-coupling agent, EEDQ, on 5-HT 2A receptor binding and function in rat frontal cortex

Zotepine: Preclinical support for antidepressant activity

Dopamine D2 receptors : a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments

Dopamine D 2 receptors: A potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments

Binding of zotepine to serotonin (5-HT) receptor subtypes

Neurotransmitters and their receptors in post-mortem brain from depressed suicide victims

[ 3H]5-hydroxytryptamine binding sites in postmortem human brain

The inhibition constants for blockade of [3H]5-hydroxytryptamine reuptake are variable and dependent on a tissue concentration

CHAPTER 6 - POST-MORTEM STUDIES OF NEUROTRANSMITTER BIOCHEMISTRY IN DEPRESSION AND SUICIDE

Brain 5-HT Uptake Sites, Labelled with [3H]Paroxetine, in Depressed Suicides

Key features of palliative care service delivery to Indigenous peoples in Australia, New Zealand, Canada and the United States: a comprehensive review

An Exploration of Underrepresentation of Aboriginal Cancer Patients Attending a Regional Radiotherapy Service in Western Australia

Hypercalcaemia in relapsed medulloblastoma 8 years post-diagnosis; evidence to support PTHrP production by medulloblastoma cells

Hydroxyapatite Ceramics from Hydrothermally Prepared Powders

Suchergebnisse filtern